Skip to content
Journal article

Nanocarriers as an emerging platform for cancer therapy

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R ...see all

Nature Nanotechnology, vol. 2, issue 12 (2007) pp. 751-760

  • 1.8k

    Readers

    Mendeley users who have this article in their library.
  • 3.6k

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Dan Peer

  • Jeffrey M. Karp

  • Seungpyo Hong

  • Omid C. Farokhzad

  • Rimona Margalit

  • Robert Langer

Cite this document

Choose a citation style from the tabs below